// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Formin Dependent Regulation of Adherens Junction Assembly

John W Copeland - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Improved Clinical Performance and Teamwork of Pediatric Interprofessional Resuscitation Teams with a Simulation-based Educational Intervention

Deanna Koot - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Papillon-Lefevre syndrome

N/A

Metabolic Regulation by miR-33 in Macrophages Controls Immune Effector Responses

Hasini Ediriweera - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Conversion of Tumor Microvessels into a Hierarchical and Vasoreactive Network, and Suppression of Metastases, by Fibroblast Growth Factor 9

Hao Yin - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Renal cell carcinoma

Nitric oxide

Catechol-O-Methyl Transferase Methylation and Blood Pressure in Children Treated With Second-generation Antipsychotics

Kaia V Hookenson - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertension

N/A

Loss of Smooth Muscle ?-actin in Mice Results in Thoracic Aortic Aneurysms via Increased Reactive Oxygen Species, Increased Nox4,and Increased Angiotensin II type 1 Receptor-Mediated Signaling

Callie Kwartler - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Angiotensin II

Exacerbation of Arterial Stiffness in Obese Adiponectin Deficient Mice

Carla Taylor - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Arterial stiffness

N/A

Prevalence of Fredrickson-Levy Dyslipidemia Phenotypes at Extreme HDL-C Levels: The Very Large Database of Lipids (VLDL-9B)

Mohammed Al-Hijji - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dyslipidemia

N/A

Impact of Insulin-resistance, Body Mass Index and Dietary Fat Intakes on Apolipoprotein B-48 Kinetic

Andre J Tremblay - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ApoA-I Mimetic Peptide Treatment Improves Left Ventricular Diastolic Dysfunction and Decreases Iron Content in Coronary Plaques in Rabbits

David Busseuil - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular diastolic dysfunction

Ergocalciferol

Characterization of the Lipase Stimulating Domain for Apolipoprotein A-V and the Development of a Therapeutic Peptide for the Treatment of Hypertriglyceridemia

Kim Munro - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Dyslipidemia

Heparin

Salicylate Restores Macrophage Cholesterol Homeostasis via Activation of AMP-Activated Protein Kinase

Chelsea P McGregor - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

A-769662

FTY720 Protects Against Diet Induced Coronary Artery Disease and Myocardial Infarction in Diabetic SR-B1-/- ApoE-Hypomorphic Mice

Geoff Werstuck - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Coronary Artery Disease

Streptozotocin

Lymphatic Function Is Impaired Before Atherosclerosis Onset in a Model of Atherosclerosis-prone Mice

Marie-Elaine Clavet-Lanthier - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Atherogenic Macrophages Transfer microRNA-containing Exosomes to Naive Cells and Promote Macrophage Migration

Denuja Karunakaran - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Renal Impairment, Carotid Plaque Burden and Stenosis: Only Partly Explained by Homocysteine

J. David Spence - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Renal insufficiency

Clindamycin and Benzoyl Peroxide

Role of Micro RNA LET-7F in Cigarette Smoke-Induced Impairment of Neovascularization

Sylvie Dussault - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Characterization of Microparticles Formed by ABCA1

John K Bielicki - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

cyclodextrin

Tie2 Deficiency Leads to Lymphatic Defects and Resistance to High-fat Diet Induced Obesity

Benjamin R Thomson - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Sequential and Post-procedure ASPECTS Predict Clinical Outcome in Mechanical Thrombectomy of Acute Anterior Circulation Ischemic Stroke

Osama O. Zaidat - American Heart Association (AHA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Copyright © 2026. QuantiNova All rights reserved